NCT02873026View on ClinicalTrials.gov

Adjunctive Steroid Combination in Ocular Trauma (ASCOT) Study

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2020

Study Completion Date

January 31, 2021

Conditions
Eye Injury Trauma
Interventions
DRUG

Triamcinolone Acetonide

Following the repair of the open globe eye trauma, the use of Triamcinolone Acetonide will be investigated

Trial Locations (1)

Unknown

Moorfields Eye Hospital, London

All Listed Sponsors
lead

Moorfields Eye Hospital NHS Foundation Trust

OTHER

NCT02873026 - Adjunctive Steroid Combination in Ocular Trauma (ASCOT) Study | Biotech Hunter | Biotech Hunter